Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06704919 · ClinicalTrials.gov registry record
Conduit Cages and Fibergraft BG Putty
A clinical trial of Degenerative Disc Disease and Herniated Disc, sponsored by Nitin Agarwal.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06704919 is a study of Degenerative Disc Disease and Herniated Disc that is actively recruiting participants, run by Nitin Agarwal. The registered enrollment target is 100 participants, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06704919, a study of Degenerative Disc Disease and Herniated Disc, is actively recruiting participants, sponsored by Nitin Agarwal.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The Conduit cages are intended to restore the intervertebral height and to facilitate the intervertebral body fusion in the cervical and lumbar spine in skeletally mature patients with degenerative disc disease and instabilities at one or more levels of the spine. The Fibergraft Bioactive Glass (BG) is engineered to mimic the body's natural bone healing process. While previous studies have described the use of conduit cages in interbody fixation procedures, these studies did not specifically study the clinical and radiographic outcomes of patients who have received these implants in addition to Fibergraft. We aim to recruit patients with degenerative disc disease, and instabilities at one to multilevel contiguous levels between C2-T1 and 1-2 contiguous levels between L2-S1 of the spine with accompanying radicular symptoms, ruptured or herniated discs, and pseudarthrosis and spondylodesis. We will then follow these patients for a duration of two years to report their clinical and radiographic outcomes to determine fusion, complication rate, and revision surgeries if any.
Conditions Studied
Interventions
- DEVICE Use of conduit cages and fibergraft BG Putty
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2029-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06704919
The ClinicalTrials.gov registry entry for NCT06704919 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (40% lower). The listed sponsor is Nitin Agarwal, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Use of conduit cages and fibergraft BG Putty is the first listed.
NCT06704919 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06704919 about?
NCT06704919 is a clinical study titled "Conduit Cages and Fibergraft BG Putty". The Conduit cages are intended to restore the intervertebral height and to facilitate the intervertebral body fusion in the cervical and lumbar spine in skeletally mature patients with degenerative disc disease and instabilities at one or more levels of the spine. The Fibergraft Bioactive Glass (BG)...
What is the current status of trial NCT06704919?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-11-04. Estimated completion is 2029-03-30.
What conditions does trial NCT06704919 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Herniated Disc.
What interventions are being tested in trial NCT06704919?
The interventions under investigation include: Use of conduit cages and fibergraft BG Putty (DEVICE).
Who is sponsoring clinical trial NCT06704919?
This trial is sponsored by Nitin Agarwal, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06704919 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.